Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes

Encapsulation of Doxorubicin (Dox), a potent cytotoxic agent and immunogenic cell death inducer, in pegylated (Stealth) liposomes, is well known to have major pharmacologic advantages over treatment with free Dox. Reformulation of alendronate (Ald), a potent amino-bisphosphonate, by encapsulation in...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Alberto Gabizon, Hilary Shmeeda, Benjamin Draper, Ana Parente-Pereira, John Maher, Amaia Carrascal-Miniño, Rafael T. M. de Rosales, Ninh M. La-Beck
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-11-01
Serie:	Pharmaceutics
Soggetti:	liposome doxorubicin alendronate co-encapsulation chemotherapy immunotherapy
Accesso online:	https://www.mdpi.com/1999-4923/15/11/2606
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!